Publications

Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C. & Verny, C. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris), 172(8-9), 423-432. doi:10.1016/j.neurol.2016.07.012

Fenelon, G. (2019). Hallucinations visuelles. In Hélène Amievia, Antoinette Prouteau, Olivier Martinaud (Eds.), Neuropsychologie en psychiatrie

Cleret de Langavant, L., Trinkler, I., Cesaro, P. & Bachoud-Levi, A. (2009). Heterotopagnosia: When I point at parts of your body. Neuropsychologia, 47(7), 1745-55. doi:10.1016/j.neuropsychologia.2009.02.016

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076

Villafane, G., Thiriez, C., Audureau, E., Straczek , C., Kerschen, P., Cormier-Dequaire , F., Van Der Gucht, A., Gurruchaga, J., Evangelista, E., Defer, G., Damier, P., Remy, P., Itti, E., Fenelon, G. & Quéré-Carne M, M. (2017). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol , 25, 120-127. doi:10.1111/ene.13474

Squitieri, F., Gellera, C., Cannella, M., Mariotti, C., Cislaghi, G., Rubinsztein, D., Almqvist, E., Turner, D., Bachoud-Levi, A., Simpson, S., Delatycki, M., Maglione, V., Hayden, M. & Donato, S. (2003). Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain : a journal of neurology, 126(Pt 4), 946-55.

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Bachoud-Levi, A., (Et Al), . & Cleret de Langavant, L. (2020). Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Movement disorders, 35(8), 1323-1335. doi:10.1002/mds.28201

De Gelder, B., Van Den Stock, J., Balaguer Rde, D. & Bachoud-Levi, A. (2008). Huntington's disease impairs recognition of angry and instrumental body language. Neuropsychologia, 46(1), 369-73. doi:10.1016/j.neuropsychologia.2007.10.015

Moss, D., Pardiñas , A., Langbehn, D., Leavitt, B., Roos, R., Durr, A., Mead, S., Track-Hd, i., Registry, i., Holmans, P., Jones, L., Tabrizi, S. & Bachoud-Levi, A. (2017). Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurol., 16(9), 701-711. doi:10.1016/S1474-4422(17)30161-8

Riad, R., Bachoud-Levi, A., Rudzicz , F. & Dupoux, E. (2020). Identification of primary and collateral tracks in stuttered speech. , Vol. Proceedings of The 12th Language Resources and Evaluation Conference: In LREC, European Language Resources Association, 1681–1688.

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2018). Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714. J Nucl Med, 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2017). Impact of endothelial TSPO on the quantification of 18F-DPA-714. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Kuhnast, B., Leroy, C., Remy, P., Stankoff, B. & Bottlaender, M. (2018). Impact of endothelial TSPO on the quantification of 18F-DPA714 in the normal human brain. , 59(2), 307-314. doi:10.2967/jnumed.117.195396

Bachoud-Levi, A., Dormeuil, A. & Jacquemot, C. (2022). Improving efficacy of aphasia rehabilitation by using Core Assessment of Language Processing. Annals of Physical and Rehabilitation Medicine, 66(6), 101630. doi:10.1016/j.rehab.2022.101630

Jacquemot, C., Lalanne, C., Sliwinski, A., Piccinini, P., Dupoux, E. & Bachoud-Levi, A. (2019). Improving language evaluation in neurological disorders: The French Core Assessment of Language Processing (CALAP). Psychological assessment, 31(5), 622-630. doi:10.1037/pas0000683

Douaud, G., Behrens, T., Poupon, C., Cointepas, Y., Jbabdi, S., Gaura, V., Golestani, N., Krystkowiak, P., Verny, C., Damier, P., Bachoud-Levi, A., Hantraye, P. & Remy, P. (2009). In vivo evidence for the selective subcortical degeneration in Huntington's disease. NeuroImage, 46(4), 958-66. doi:10.1016/j.neuroimage.2009.03.044

Bayen , E., Cleret de Langavant, L., Youssov, K. & Bachoud-Levi, A. (2023). Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors. Annals of physical and rehabilitation medicine, 66(4), 101703. doi:10.1016/j.rehab.2022.101703

Chambon, V., Thero, H., Vidal, M., Vandendriessche, H., Haggard, P. & Palminteri, S. (2020). Information about action outcomes differentially affects learning from self-determined versus imposed choices. Nature Human Behaviour , 4, 1067-1079. doi:10.1038/s41562-020-0919-5

Salem, L., Saleh, N., Désaméricq, G., Youssov, K., Dolbeau, G., Cleret de Langavant, L., Bourhis, M., Azulay, J., Krystkowiak, P., Verny, C., Morin, F., Moutereau, S., French Huntington Study, G., Bachoud-Levi, A. & Maison, P. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PloS one, 11(9), e0162890. doi:10.1371/journal.pone.0162890

Peschanski, M., Bachoud-Levi, A. & Hantraye, P. (2004). Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain : a journal of neurology, 127(Pt 6), 1219-28. doi:10.1093/brain/awh145

Bachoud-Levi, A., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., Squitieri, F., Seppi, K., Perrine, C., Scherer-Gagou, C., Audrey, O., Verny, C. & Burgunder, J. (2019). International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology, 10, 710. doi:10.3389/fneur.2019.00710

Poli, M. , Dupoux, E. & Riad, R. (2023). Introducing Topography in Convolutional Neural Networks. In CASSP 2023 - 2023 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), Rhodes Island, Greece, 1-5. doi:10.1109/ICASSP49357.2023.10096671

De Gelder, B., Bachoud-Levi, A. & Degos, J. (1998). Inversion superiority in visual agnosia may be common to a variety of orientation polarised objects besides faces. Vision Research, 38(18), 2855-2861. doi:10.1016/S0042-6989(97)00458-6

Jacquemot, C., Dupoux, E. & Bachoud-Levi, A. (2011). Is the word-length effect linked to subvocal rehearsal? Cortex, 47(4), 484-493. doi:10.1016/j.cortex.2010.07.007

Trinkler, I., Cleret de Langavant, L. & Bachoud-Levi, A. (2013). Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex; a journal devoted to the study of the nervous system and behavior, 49(2), 549-58. doi:10.1016/j.cortex.2011.12.003

Le Stanc, L., Youssov, K., Giavazzi, M., Sliwinski, A., Bachoud-Levi, A. & Jacquemot, C. (2023). Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance. Cortex; a journal devoted to the study of the nervous system and behavior, 166, 91-106. doi:10.1016/j.cortex.2023.04.016

Teichmann, M., Gaura, V., Démonet, J., Supiot, F., Delliaux, M., Verny, C., Renou, P., Remy, P. & Bachoud-Levi, A. (2008). Language processing within the striatum: evidence from a PET correlation study in Huntington's disease. Brain : a journal of neurology, 131(Pt 4), 1046-56. doi:10.1093/brain/awn036

Jacquemot, C. (2016). Le langage d’hier à aujourd’hui. Les grands dossier de Sciences Humaines, Etat des lieux en Psychologie, 24-27.

Jacquemot, C. (2017). Le langage fait l’homme et l’homme fait le langage. Paris: Sciences Humaines Editions